Canada markets open in 6 hours 21 minutes

Collegium Pharmaceutical, Inc. (COLL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
34.74-0.10 (-0.29%)
At close: 04:00PM EDT
34.74 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.14B
Enterprise Value 1.50B
Trailing P/E 26.95
Forward P/E 5.62
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.56
Price/Book (mrq)5.82
Enterprise Value/Revenue 2.65
Enterprise Value/EBITDA 4.87

Trading Information

Stock Price History

Beta (5Y Monthly) 1.04
52-Week Change 352.50%
S&P500 52-Week Change 323.06%
52 Week High 340.95
52 Week Low 320.83
50-Day Moving Average 336.81
200-Day Moving Average 328.40

Share Statistics

Avg Vol (3 month) 3406.39k
Avg Vol (10 day) 3324.95k
Shares Outstanding 532.71M
Implied Shares Outstanding 632.71M
Float 828.8M
% Held by Insiders 11.41%
% Held by Institutions 1122.86%
Shares Short (Mar 28, 2024) 47.12M
Short Ratio (Mar 28, 2024) 414.17
Short % of Float (Mar 28, 2024) 426.89%
Short % of Shares Outstanding (Mar 28, 2024) 421.76%
Shares Short (prior month Feb 29, 2024) 46.72M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 8.50%
Operating Margin (ttm)41.19%

Management Effectiveness

Return on Assets (ttm)10.28%
Return on Equity (ttm)24.68%

Income Statement

Revenue (ttm)566.77M
Revenue Per Share (ttm)16.80
Quarterly Revenue Growth (yoy)15.50%
Gross Profit (ttm)N/A
EBITDA 339.83M
Net Income Avi to Common (ttm)48.16M
Diluted EPS (ttm)1.29
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)310.55M
Total Cash Per Share (mrq)9.72
Total Debt (mrq)674.28M
Total Debt/Equity (mrq)345.02%
Current Ratio (mrq)1.17
Book Value Per Share (mrq)6.13

Cash Flow Statement

Operating Cash Flow (ttm)274.75M
Levered Free Cash Flow (ttm)274.32M